Examiner Stephen Elmore
Grant ratio: 94.9% (94th percentile in Art Unit 2188 among examiners with at least 20 applications). Average office actions per grant: 1.21.
Appears inactive
Last office action in data: October 2017
Examiner record
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 11 | 22.6% | 1.74 |
| Group | 178 | 52.5% | 1.89 |
| Tech Center | 1,781 | 52.8% | 2.19 |
| USPTO | 16,475 | 52.7% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 222 | 81.3% |
| 2 OAs | 41 | 15.0% |
| 3 OAs | 8 | 2.9% |
| 4 OAs | 2 | 0.7% |
| 5+ OAs | 0 | 0.0% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2008 | 21 | 20 | 95.2% |
| 2009 | 34 | 31 | 91.2% |
| 2010 | 31 | 31 | 100.0% |
| 2011 | 23 | 19 | 82.6% |
| 2012 | 24 | 22 | 91.7% |
| 2013 | 31 | 31 | 100.0% |
| 2014 | 35 | 35 | 100.0% |
| 2015 | 30 | 28 | 93.3% |
| 2016 | 22 | 22 | 100.0% |
| 2017 | 22 | 20 | 90.9% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 273 | 23.8% | 15.4% | 12.5% | 23.8% |
| Action 2 | 51 | 29.4% | 13.7% | 23.5% | 17.6% |
| Action 3 | 10 | 10.0% | 30.0% | 50.0% | 10.0% |
| Action 4 | 2 | 0.0% | 0.0% | 100.0% | 0.0% |
Section 101 rejections
Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.
By year
9.4%
5.0%
16.2%
36.7%
32.1%
42.1%
2014: Alice
43.9%
28.9%
19.2%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Aug. 27, 2026.